Profile data is unavailable for this security.
About the company
Shenzhen Chipscreen Biosciences Co Ltd is a China-based company mainly engaged in the research and development of original innovative drugs. The Company focuses on the research and development of original innovative drugs in five therapeutic areas, including malignant tumors, metabolic diseases, autoimmune diseases, central nervous system diseases and anti-virus. The Company's main products include Chidamide, Siglitazone, Cioroni and CS12192. The Company mainly conducts its businesses in the domestic market.
- Revenue in CNY (TTM)547.79m
- Net income in CNY103.01m
- Incorporated2001
- Employees1.06k
- LocationShenzhen Chipscreen Biosciences Co Ltd21F-24F, Building B, Zhigu Industrial Park, Shuguang CommunSHENZHEN 518057ChinaCHN
- Phone+86 75 526952070
- Fax+86 75 526957291
- Websitehttps://www.chipscreen.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Beijing Foyou Pharma Co Ltd | 3.32bn | 507.64m | 6.71bn | 3.44k | 13.17 | 1.90 | -- | 2.02 | 1.06 | 1.06 | 6.95 | 7.35 | 0.7482 | 3.46 | 9.58 | 967,165.90 | 11.50 | -- | 14.81 | -- | 65.14 | -- | 15.37 | -- | 2.99 | -- | 0.0316 | -- | 3.07 | -- | 11.36 | -- | -- | -- |
Harbin Pharmaceutical Group Co., Ltd. | 15.67bn | 449.71m | 6.75bn | 9.85k | 14.67 | 1.38 | -- | 0.4308 | 0.1827 | 0.1827 | 6.34 | 1.95 | 1.13 | 6.35 | 3.46 | 1,590,093.00 | 3.79 | 0.7414 | 10.20 | 1.89 | 26.30 | 23.87 | 3.35 | 0.7294 | 1.06 | 40.41 | 0.393 | 0.00 | 11.93 | 7.41 | -14.88 | 2.69 | -5.38 | -- |
Lushang Freda Pharmaceutical Co Ltd | 4.20bn | 233.09m | 6.75bn | 3.65k | 28.96 | 1.66 | -- | 1.61 | 0.2293 | 0.2293 | 4.13 | 4.01 | 0.4446 | 0.8832 | 7.75 | 1,149,606.00 | 3.02 | 0.6992 | 5.84 | 5.12 | 48.44 | 20.23 | 6.79 | 3.45 | 2.67 | -- | 0.1251 | 40.33 | -64.65 | -12.29 | 567.44 | 13.36 | 44.40 | 14.87 |
Shenzhen Chipscreen Biosciences Co Ltd | 547.79m | 103.01m | 6.98bn | 1.06k | 66.41 | 4.13 | -- | 12.74 | 0.2578 | 0.2578 | 1.33 | 4.15 | 0.1761 | 1.66 | 3.97 | 518,248.70 | 2.14 | 1.32 | 2.61 | 1.54 | 86.99 | 93.29 | 12.17 | 6.97 | 2.99 | -- | 0.4037 | 0.00 | -1.18 | 28.81 | 408.09 | 23.31 | 10.23 | -- |
North China Pharmaceutical Co Ltd | 10.02bn | 17.62m | 7.31bn | 10.16k | 414.80 | 1.37 | -- | 0.7296 | 0.0103 | 0.0103 | 5.84 | 3.11 | 0.4693 | 2.71 | 4.31 | 986,082.90 | 0.3543 | -0.2978 | 0.8122 | -0.7042 | 30.26 | 35.73 | 0.755 | -0.5985 | 0.5425 | 1.43 | 0.6473 | -- | -3.62 | 1.89 | 100.71 | -49.62 | 4.22 | -19.73 |
Jianmin Pharmaceutical Group Co Ltd | 4.17bn | 521.42m | 7.36bn | 2.50k | 14.08 | 3.13 | -- | 1.77 | 3.41 | 3.41 | 27.26 | 15.35 | 1.04 | 5.81 | 4.34 | 1,669,960.00 | 13.09 | 10.87 | 23.66 | 19.11 | 43.70 | 43.04 | 12.56 | 9.32 | 1.26 | -- | 0.1891 | 37.15 | 15.72 | 14.28 | 27.78 | 45.05 | 8.77 | 43.10 |
China Animal Husbandry Industry Co., Ltd | 5.47bn | 339.08m | 7.42bn | 4.33k | 21.89 | 1.33 | -- | 1.36 | 0.3321 | 0.3321 | 5.36 | 5.48 | 0.6331 | 4.13 | 4.89 | 1,264,384.00 | 3.33 | 6.23 | 4.71 | 9.01 | 18.95 | 24.29 | 5.26 | 8.69 | 1.86 | -- | 0.2017 | 31.20 | -8.24 | 4.04 | -26.73 | -0.6127 | 24.20 | -3.77 |
Data as of Jul 05 2024. Currency figures normalised to Shenzhen Chipscreen Biosciences Co Ltd's reporting currency: Chinese Yuan Renminbi CNY
Holder | Shares | % Held |
---|---|---|
Bosera Asset Management Co., Ltd.as of 31 Dec 2023 | 3.54m | 0.86% |
Penghua Fund Management Co., Ltd.as of 31 Dec 2023 | 3.17m | 0.77% |
Da Cheng Fund Management Co., Ltd.as of 31 Dec 2023 | 1.84m | 0.45% |
The Vanguard Group, Inc.as of 06 Jun 2024 | 1.25m | 0.30% |
China Asset Management Co., Ltd.as of 31 Dec 2023 | 1.20m | 0.29% |
China Universal Asset Management Co., Ltd.as of 31 Dec 2023 | 1.06m | 0.26% |
Fullgoal Fund Management Co., Ltd.as of 31 Dec 2023 | 951.56k | 0.23% |
China Southern Asset Management Co., Ltd.as of 31 Dec 2023 | 451.04k | 0.11% |
AXA-SPDB Investment Managers Co., Ltd.as of 31 Dec 2023 | 416.33k | 0.10% |
E Fund Management Co., Ltd.as of 31 Dec 2023 | 399.60k | 0.10% |
More ▼
Data from 31 Dec 2023 - 03 Jul 2024Source: FactSet Research Systems Inc.